A Review of the Efficacy and Safety of Genvoya(®) (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.

about

Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase

P2860

Q50059498-68AC55BD-AC0D-4E14-9A7E-6D63BACB5630 Q58760446-C40A0F3F-AB42-4367-B427-028B286B13CE

P2860

A Review of the Efficacy and Safety of Genvoya(®) (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.

Item

http://www.wikidata.org/entity/Q38756133

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Review of the Efficacy and S ...... Management of HIV-1 Infection.

@en

type

Item

label

A Review of the Efficacy and S ...... Management of HIV-1 Infection.

@en

prefLabel

A Review of the Efficacy and S ...... Management of HIV-1 Infection.

@en

P1476

A Review of the Efficacy and S ...... Management of HIV-1 Infection.

@en

P2093

Ayşe Elif Özdener

http://www.w3.org/2001/XMLSchema#string

Sara A Angione

http://www.w3.org/2001/XMLSchema#string

Sibyl M Cherian

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.

In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate.

Characterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): a review of its use in the management of HIV-1 infection in adults.

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.

P304

897190017710519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0897190017710519

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28558493

http://www.w3.org/2001/XMLSchema#string

A Review of the Efficacy and Safety of Genvoya(®) (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.

about

P2860

P2860

A Review of the Efficacy and Safety of Genvoya(®) (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) in the Management of HIV-1 Infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698